GenMont Biotech Incorporation

Informe acción TWSE:3164

Capitalización de mercado: NT$1.8b

GenMont Biotech Incorporation Dirección

Dirección controles de criterios 0/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEOno data
Participación del CEOn/a
Permanencia media de la direcciónsin datos
Promedio de permanencia en la Junta Directivasin datos

Actualizaciones recientes de la dirección

Recent updates

We Think That There Are More Issues For GenMont Biotech Incorporation (TWSE:3164) Than Just Sluggish Earnings

Mar 19
We Think That There Are More Issues For GenMont Biotech Incorporation (TWSE:3164) Than Just Sluggish Earnings

Should You Or Shouldn't You: A Dividend Analysis on GenMont Biotech Incorporation (TPE:3164)

Apr 04
Should You Or Shouldn't You: A Dividend Analysis on GenMont Biotech Incorporation (TPE:3164)

GenMont Biotech Incorporation's(TPE:3164) Share Price Is Down 26% Over The Past Five Years.

Feb 14
GenMont Biotech Incorporation's(TPE:3164) Share Price Is Down 26% Over The Past Five Years.

Is GenMont Biotech Incorporation's (TPE:3164) Recent Price Movement Underpinned By Its Weak Fundamentals?

Jan 24
Is GenMont Biotech Incorporation's (TPE:3164) Recent Price Movement Underpinned By Its Weak Fundamentals?

Tread With Caution Around GenMont Biotech Incorporation's (TPE:3164) 3.5% Dividend Yield

Jan 03
Tread With Caution Around GenMont Biotech Incorporation's (TPE:3164) 3.5% Dividend Yield

Are GenMont Biotech Incorporation's (TPE:3164) Statutory Earnings A Good Guide To Its Underlying Profitability?

Dec 08
Are GenMont Biotech Incorporation's (TPE:3164) Statutory Earnings A Good Guide To Its Underlying Profitability?

CEO

GenMont Biotech Incorporation no tiene CEO, o no tenemos datos al respecto.